158 related articles for article (PubMed ID: 24340082)
1. A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.
Huang L; Liu Z; Chen S; Liu Y; Shao Z
PLoS One; 2013; 8(12):e83081. PubMed ID: 24340082
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y
PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
Zenzola V; Cabezas-Quintario MA; Arguelles M; Pérez-Fernández E; Izarzugaza Y; Correa A; García-Foncillas J
Clin Transl Oncol; 2018 Nov; 20(11):1448-1454. PubMed ID: 29671222
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer.
Chen S; Chen CM; Yu KD; Yang WT; Shao ZM
J Surg Oncol; 2012 May; 105(6):577-85. PubMed ID: 22065549
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas.
Mrklić I; Ćapkun V; Pogorelić Z; Tomić S
Pathol Res Pract; 2013 May; 209(5):296-301. PubMed ID: 23601837
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
[TBL] [Abstract][Full Text] [Related]
9. New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer.
Hao S; He ZX; Yu KD; Yang WT; Shao ZM
Oncotarget; 2016 Apr; 7(17):24824-31. PubMed ID: 27050075
[TBL] [Abstract][Full Text] [Related]
10. The prognostic and predictive potential of Ki-67 in triple-negative breast cancer.
Zhu X; Chen L; Huang B; Wang Y; Ji L; Wu J; Di G; Liu G; Yu K; Shao Z; Wang Z
Sci Rep; 2020 Jan; 10(1):225. PubMed ID: 31937819
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prognostic factors related to triple-negative breast cancer].
Shen SJ; Sun Q; Zhou YD; Guan JH; Mao F; Lin Y; Peng L; Xu Y; Wang XF; Xia W; Yao R; Han SM
Zhonghua Wai Ke Za Zhi; 2013 Nov; 51(11):1000-4. PubMed ID: 24444685
[TBL] [Abstract][Full Text] [Related]
12. P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
Pan Y; Yuan Y; Liu G; Wei Y
PLoS One; 2017; 12(2):e0172324. PubMed ID: 28235003
[TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
Ricciardi GR; Adamo B; Ieni A; Licata L; Cardia R; Ferraro G; Franchina T; Tuccari G; Adamo V
PLoS One; 2015; 10(6):e0128368. PubMed ID: 26039245
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.
Schmidt G; Meyberg-Solomayer G; Gerlinger C; Juhasz-Böss I; Herr D; Rody A; Liedtke C; Solomayer EF
Arch Gynecol Obstet; 2014 Dec; 290(6):1221-9. PubMed ID: 25012601
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
[TBL] [Abstract][Full Text] [Related]
16. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
18. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
19. The role of Ki-67 in Asian triple negative breast cancers: a novel combinatory panel approach.
Tan AS; Yeong JPS; Lai CPT; Ong CHC; Lee B; Lim JCT; Thike AA; Iqbal J; Dent RA; Lim EH; Tan PH
Virchows Arch; 2019 Dec; 475(6):709-725. PubMed ID: 31407032
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of ECT2 in invasive breast cancer.
Wang HK; Liang JF; Zheng HX; Xiao H
J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
